31 – 36 of 36
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- 3
- 4
- next »
- 2006
-
Mark
Two-year outcome of Galantamine treatment in Alzheimer’s disease in a routine clinical setting.
2006) 9th International Geneva/Springfield Symposium on Advances in Alzheimer Therapy(
- Contribution to conference › Poster
-
Mark
Clusterin in cerebrospinal fluid: analysis of carbohydrates and quantification of native and glycosylated forms
(
- Contribution to journal › Article
- 2005
-
Mark
Analysis of the heterogeneity in treatment response to Donepezil in Alzheimer’s disease conclusions from the Swedish Alzheimer Treatment Study Group.
(
- Contribution to conference › Poster
- 2003
-
Mark
Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease
(
- Contribution to journal › Article
- 2002
-
Mark
Studies of the pathophysiological mechanisms in frontotemporal dementia by proteome analysis of CSF proteins
(
- Contribution to journal › Article
-
Mark
Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients
(
- Contribution to journal › Article
- « previous
- 1
- 2
- 3
- 4
- next »